Post-percutaneous coronary intervention angina: From physiopathological mechanisms to individualized treatment

Leonardo De Luca1, Giuseppe M C Rosano2, Ilaria Spoletini2

  • 1Department of Cardiosciences, A.O. San Camillo Forlanini, Roma, Italy. leo.deluca@libero.it.

Cardiology Journal
|April 12, 2021
PubMed

Insights

Chronic ischemic heart disease (IHD) can persist after percutaneous coronary intervention (PCI). This review explores the causes, diagnosis, and management of ongoing angina following PCI, aiming to improve patient outcomes.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Medical Research

Background:

  • Chronic ischemic heart disease (IHD) is a complex condition with diverse causes.
  • Percutaneous coronary intervention (PCI) is a common treatment to reduce angina in IHD patients.
  • Persistent anginal symptoms post-PCI negatively impact quality of life and prognosis.

Purpose of the Study:

  • To review the pathogenic mechanisms of angina after PCI.
  • To outline the diagnostic challenges of post-PCI angina.
  • To discuss management strategies for patients experiencing angina post-PCI.

Main Methods:

  • Literature review of pathogenic mechanisms.
  • Analysis of diagnostic approaches for persistent angina.
  • Synthesis of current management guidelines and therapeutic options.

Main Results:

  • Identified multifactorial etiologies for post-PCI angina.
  • Highlighted difficulties in diagnosing the precise cause of residual symptoms.
  • Summarized therapeutic interventions and their limitations.

Conclusions:

  • Post-PCI angina remains a significant clinical challenge.
  • Understanding underlying mechanisms is crucial for effective diagnosis and management.
  • Further research is needed to optimize treatment strategies for improved patient outcomes.

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
106
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
132
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
107
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
75
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
90
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
77